Comparison of Diclofenac vs. Nepafenac Ophthalmic Drops: Patient Comfort
NCT02506348 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2015-07-24
Summary
In this study we test Diclofenac and Nepafenac and compared patients experience and comfort following administration of these ophthalmic drops.
Conditions
- Post Surgical Management
- Pain Management
- Inflamation Management
Interventions
- DRUG
-
Diclofenac
- DRUG
-
Nepafenac
Sponsors & Collaborators
-
Wolfson Medical Center
lead OTHER_GOV
Study Design
- Allocation
- NA
- Masking
- SINGLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-07-31
- Primary Completion
- 2016-01-31
Countries
- Israel
Study Locations
More Related Trials
-
Nepafenac 0.1% Eye Drops, Suspension Compared to Ketorolac Trometamol 0.5% Eye Drops, Solution and Placebo
NCT00405730 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Topical Nepafenac 0.1% on Pain Related to Intravitreal Injections
NCT02821390 ·Status: COMPLETED ·Phase: NA
-
Comparison of Treatment With Preservative-free Dexamethasone 0.1% (Monofree Dexamethason) and Diclofenac 0.1% (Dicloabak) Eye Drops Versus Preserved Dexamethasone 0.1% (Maxidex) and Diclofenac 0.1% (Voltaren Ophtha) Eye Drops After Cataract Surgery
NCT04050644 ·Status: RECRUITING ·Phase: PHASE4
-
Prophylactic Nepafenac and Ketorolac Versus Placebo in Patients Undergoing Cataract Surgery
NCT01395069 ·Status: COMPLETED ·Phase: PHASE4
-
Nepafenac Compared to Placebo for Ocular Pain and Inflammation
NCT01426854 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Topical and Oral Diclofenac on Pain Related to Intravitreal Injections
NCT02837770 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Necessity of Anti-inflammatory Drops After Laser Peripheral Iridotomy
NCT02955641 ·Status: UNKNOWN ·Phase: NA
-
Clinical Endpoint Study of Nepafenac 0.3% Opthalmic Suspension
NCT03499873 ·Status: COMPLETED ·Phase: PHASE3
-
Acular LS vs. Nevanac in Post op Inflammation Following Cataract Surgery
NCT00348582 ·Status: COMPLETED ·Phase: PHASE4
-
Preoperative Topic Diclofenac as a Prevention of Postoperative Macular Edema in Patients With Diabetic Retinopathy
NCT01694212 ·Status: COMPLETED ·Phase: NA
-
A Comparison of Topical Nepafenac to Placebo in Corneal Epithelial Healing Times and Postoperative Pain Relief
NCT00330798 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Compare Ocular Safety and Tolerability of Eye Drops Containing Prednisolone Acetate in Patients With Intraocular Inflammation After Cataract Surgery
NCT00170729 ·Status: COMPLETED ·Phase: PHASE4
-
Bromday Versus Nevanac Eye Drops to Control Pain Following Photorefractive Keratectomy
NCT01475877 ·Status: COMPLETED
-
Cross-Over Evaluation of Two Lubricating Eye Drops
NCT00493662 ·Status: COMPLETED ·Phase: PHASE4
-
Nepafenac Versus Ketorolac Eye Drops in Prevention of Intraoperative Miosis During Cataract Surgery
NCT03851172 ·Status: UNKNOWN ·Phase: PHASE2
-
Steroids Versus Non-steroidal Anti-inflammatory Drugs Following Glaucoma Surgery
NCT00956462 ·Status: UNKNOWN ·Phase: NA
-
Topical Diclofenac on Macular Thickness After Phacoemulsification
NCT02306031 ·Status: UNKNOWN ·Phase: PHASE2
-
Aqueous Concentrations and PGE2 Inhibition of Ketorolac 0.4% vs. Bromfenac 0.09% in Cataract Patients: Trough Drug Effects
NCT00469690 ·Status: COMPLETED ·Phase: PHASE4
-
Aqueous Concentrations and PGE2 Inhibition of Ketorolac 0.4% vs. Bromfenac 0.09% in Cataract Patients
NCT00347503 ·Status: COMPLETED ·Phase: PHASE4
-
Tolerability and Toxicity of Topically Applied Nepafenac 0.3% vs Ketorolac 0.5%
NCT02752646 ·Status: COMPLETED ·Phase: NA
-
Comparison of Pain Sensation During Single Use of Two Topical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
NCT00869219 ·Status: UNKNOWN ·Phase: PHASE4
-
Prednisolone Acetate Eye Drops for Pain Intervention in Second Eye Cataract Surgery
NCT06614348 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Comparison of Post Phacoemulsification Aqueous Flare in Patients Using Ketorolac 0.45% 2 Times Daily (BID) and Bromfenac 0.09% 2 Times Daily (BID)
NCT01023724 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Acular LS Versus Nevanac for Pain Control in Eyes Undergoing PRK
NCT00347204 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy Study of Topical Bromfenac Versus Placebo to Treat Ocular Inflammation After Cataract Surgery
NCT00198445 ·Status: COMPLETED ·Phase: PHASE3